Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse
The dopamine receptor D2 (encoded by DRD2 ) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6)...
Saved in:
Published in | Neuropsychopharmacology (New York, N.Y.) Vol. 36; no. 4; pp. 753 - 762 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.03.2011
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The dopamine receptor D2 (encoded by
DRD2
) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain.
DRD2
mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of
DRD2
variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of
DRD2
SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively;
p
=0.001; OR=3.4 (1.7–7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse. |
---|---|
AbstractList | The dopamine receptor D2 (encoded by DRD2) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of DRD2 variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of DRD2 SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively; p=0.001; OR=3.4 (1.7-7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse. The dopamine receptor D2 (encoded by DRD2 ) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of DRD2 variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of DRD2 SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively; p =0.001; OR=3.4 (1.7–7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse. The dopamine receptor D2 (encoded by DRD2) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of DRD2 variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of DRD2 SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively; p=0.001; OR=3.4 (1.7-7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse.The dopamine receptor D2 (encoded by DRD2) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of DRD2 variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of DRD2 SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively; p=0.001; OR=3.4 (1.7-7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse. |
Author | Mash, Deborah C Duque, Linda Sadee, Wolfgang Papp, Audrey C Smith, Ryan M Moyer, Robert A Wang, Danxin |
Author_xml | – sequence: 1 givenname: Robert A surname: Moyer fullname: Moyer, Robert A organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University – sequence: 2 givenname: Danxin surname: Wang fullname: Wang, Danxin organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University – sequence: 3 givenname: Audrey C surname: Papp fullname: Papp, Audrey C organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University – sequence: 4 givenname: Ryan M surname: Smith fullname: Smith, Ryan M organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University – sequence: 5 givenname: Linda surname: Duque fullname: Duque, Linda organization: Departments of Neurology and Molecular and Cellular Pharmacology, University of Miami School of Medicine – sequence: 6 givenname: Deborah C surname: Mash fullname: Mash, Deborah C organization: Departments of Neurology and Molecular and Cellular Pharmacology, University of Miami School of Medicine – sequence: 7 givenname: Wolfgang surname: Sadee fullname: Sadee, Wolfgang email: wolfgang.sadee@osumc.edu organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24037436$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21150907$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkttrFDEUxoNU7Lb65rMEQXxxai6Ty74Iw1ZtoaB4gb6FbCazm5JJpslMpf-9GXZrtSi-JOTkdz7Od845AgchBgvAc4xOMKLybRiGE4LKiyD5CCywqFHFaX15ABZILmmFKb08BEc5XyGEmeDyCTgkGDO0RGIBpvMwphicgZ-jv-1jGrYu9xk2XWfN6MIGNn60KejR3Vj4dfDOzMHYwbOp1wGexkH3Llh4SuAXa-wwxgSbZGGTczROj7aFP9y4hato9Mw16ynbp-Bxp322z_b3Mfj-4f231Vl18enj-aq5qAzDaCw2JGOWUCsQMWtEUEu5JGvGDBVGGi011yVAlpKKlrN2bXXLMKlbQTTVgtJj8G6nO0zr3rbGFrPaqyG5XqdbFbVTf_4Et1WbeKMoYkxQUQRe7wVSvJ5sHlXvsrHe62DjlFXpIWa85vy_pGS4FpxzVsiXD8irOJUO-xkqemU2pEAvfq_8V8l3kyvAqz2gs9G-SzoYl--5GlFR07kusuNMijkn2ynjxjLNOBt2XmGk5jVSZY3UvEblkCXpzYOkO91_4NUOzwULG5vuHf2V_wn9MNgV |
CODEN | NEROEW |
CitedBy_id | crossref_primary_10_35118_apjmbb_2024_032_1_06 crossref_primary_10_1111_eci_12463 crossref_primary_10_1021_acschemneuro_2c00425 crossref_primary_10_1016_j_drugalcdep_2015_03_003 crossref_primary_10_1007_s00702_018_1946_5 crossref_primary_10_1097_FPC_0b013e328361c39d crossref_primary_10_3390_ijerph17010365 crossref_primary_10_1038_tp_2015_176 crossref_primary_10_1371_journal_pgen_1007834 crossref_primary_10_1016_j_neuroimage_2019_06_036 crossref_primary_10_1186_s12991_018_0192_4 crossref_primary_10_1177_1933719117698582 crossref_primary_10_2217_pgs_11_23 crossref_primary_10_1016_j_neubiorev_2013_01_007 crossref_primary_10_1016_j_ygeno_2019_05_013 crossref_primary_10_2217_pgs_16_1 crossref_primary_10_1007_s12035_014_8826_2 crossref_primary_10_1016_j_forsciint_2020_110511 crossref_primary_10_1080_02640414_2015_1020841 crossref_primary_10_1002_mgg3_407 crossref_primary_10_1016_j_jpsychires_2017_03_005 crossref_primary_10_1016_j_jri_2015_04_001 crossref_primary_10_1111_adb_12489 crossref_primary_10_1186_s40246_017_0120_8 crossref_primary_10_2217_pme_2016_0100 crossref_primary_10_1172_JCI172886 crossref_primary_10_1007_s12041_018_0917_9 crossref_primary_10_1038_mp_2012_50 crossref_primary_10_7554_eLife_31924 crossref_primary_10_1093_hmg_ddv434 crossref_primary_10_1038_srep36993 crossref_primary_10_7554_eLife_09358 crossref_primary_10_1007_s12017_013_8224_3 crossref_primary_10_1007_s12035_019_1543_0 crossref_primary_10_1038_srep17996 crossref_primary_10_1016_j_pnpbp_2012_05_002 crossref_primary_10_1186_s12864_015_1749_0 crossref_primary_10_1002_mgg3_869 crossref_primary_10_1101_gr_268037_120 crossref_primary_10_1007_s10882_018_9590_4 crossref_primary_10_1038_tp_2012_146 crossref_primary_10_1016_j_phrs_2019_104283 crossref_primary_10_1038_s41598_017_10561_1 crossref_primary_10_1016_j_neubiorev_2021_08_016 crossref_primary_10_1016_j_ygeno_2014_11_009 crossref_primary_10_2217_pgs_13_58 crossref_primary_10_5483_BMBRep_2013_46_11_207 crossref_primary_10_1371_journal_pone_0072220 crossref_primary_10_1080_15622975_2017_1372630 crossref_primary_10_1186_s41021_015_0020_x crossref_primary_10_1093_brain_aww109 crossref_primary_10_3389_fpsyt_2019_00626 crossref_primary_10_3390_ijerph19169955 crossref_primary_10_3390_genes13061045 crossref_primary_10_1038_s41380_018_0125_2 crossref_primary_10_1016_j_taap_2016_06_011 crossref_primary_10_1007_s13365_013_0204_8 crossref_primary_10_1074_jbc_M113_535203 crossref_primary_10_1016_j_gde_2025_102340 crossref_primary_10_1097_YPG_0000000000000258 crossref_primary_10_1080_08820139_2019_1569677 crossref_primary_10_3390_ijms241813816 crossref_primary_10_1016_j_repbre_2024_01_003 crossref_primary_10_1097_YPG_0000000000000095 crossref_primary_10_1097_FPC_0b013e32835ff536 crossref_primary_10_1016_j_ridd_2014_04_007 crossref_primary_10_1371_journal_pone_0050086 crossref_primary_10_1016_j_neubiorev_2023_105456 crossref_primary_10_1371_journal_pone_0080613 crossref_primary_10_1038_srep13090 crossref_primary_10_3390_ijms22073781 crossref_primary_10_2478_cpp_2022_0016 crossref_primary_10_1002_ajmg_b_32179 crossref_primary_10_1002_jps_23483 crossref_primary_10_1016_j_ygeno_2017_12_003 crossref_primary_10_1089_gtmb_2020_0011 crossref_primary_10_1016_j_pnpbp_2019_03_021 crossref_primary_10_1111_ahg_12104 crossref_primary_10_1186_s12993_016_0109_9 crossref_primary_10_1038_s41598_021_02715_z crossref_primary_10_1016_j_neuron_2018_10_005 crossref_primary_10_1007_s13311_019_00828_y crossref_primary_10_1016_j_tig_2013_07_006 crossref_primary_10_3390_jcm9113593 crossref_primary_10_5402_2012_972607 crossref_primary_10_3390_brainsci10050262 crossref_primary_10_1007_s00384_018_3097_4 crossref_primary_10_1080_15622975_2024_2366235 crossref_primary_10_1038_tp_2015_114 crossref_primary_10_1007_s11756_021_00860_4 crossref_primary_10_3389_fphar_2017_00621 crossref_primary_10_1097_WNR_0b013e32834d2216 crossref_primary_10_1111_gbb_12121 crossref_primary_10_1371_journal_pone_0095997 crossref_primary_10_2147_PGPM_S326885 crossref_primary_10_1016_j_genrep_2022_101677 crossref_primary_10_1016_j_cpr_2016_11_003 crossref_primary_10_1124_mol_111_076604 crossref_primary_10_1038_tp_2012_11 crossref_primary_10_1007_s40200_021_00740_3 crossref_primary_10_1038_s41397_021_00212_0 crossref_primary_10_1111_ahg_12046 crossref_primary_10_1111_ahg_12322 crossref_primary_10_1155_2019_4678969 crossref_primary_10_1371_journal_pone_0097428 crossref_primary_10_1186_gb_2014_15_4_r65 crossref_primary_10_1007_s00439_012_1145_7 |
Cites_doi | 10.1093/nar/17.20.8093 10.1093/bioinformatics/btn564 10.1038/nature06258 10.1093/nar/17.9.3606 10.1074/jbc.M504942200 10.1523/JNEUROSCI.20-22-08305.2000 10.1002/da.20517 10.1146/annurev.pa.33.040193.001433 10.1371/journal.pone.0009348 10.1016/j.pneurobio.2004.05.006 10.1016/S0306-4522(02)00257-9 10.1016/j.pharmthera.2004.11.001 10.1080/14622200410001734030 10.1038/npp.2008.37 10.1093/brain/awn248 10.1146/annurev.neuro.29.051605.113009 10.1002/syn.890140210 10.1097/01.fpc.0000230119.34205.8a 10.2217/14622416.9.9.1285 10.1097/FBP.0b013e3283242f05 10.1007/s00213-005-2223-5 10.1038/sj.mp.4001938 10.1073/pnas.0707106104 10.1523/JNEUROSCI.4858-08.2009 10.1038/mp.2008.30 10.1016/j.neuroscience.2009.04.048 10.1097/YPG.0b013e32833a215a 10.1097/FPC.0b013e328320a3fd 10.1176/appi.ajp.2009.09040598 10.1093/hmg/6.4.577 10.1016/j.pnpbp.2009.08.024 10.2144/03345dd03 10.1038/nrg2063 10.1093/alcalc/agm030 10.1016/j.schres.2004.08.020 10.1038/sj.npp.1300861 10.1038/sj.mp.4001145 10.1016/j.neulet.2006.10.064 10.1007/s12017-008-8051-0 10.1002/ajmg.b.30876 10.1093/hmg/ddg055 10.1016/j.euroneuro.2005.09.004 10.1016/0197-0186(93)90050-F 10.1093/oxfordjournals.molbev.a004023 10.1093/hmg/ddl192 10.1111/j.1471-4159.2006.04186.x 10.1523/JNEUROSCI.3609-09.2009 10.1038/35041572 10.1017/S1461145706007152 10.1073/pnas.95.13.7731 10.1038/ejhg.2008.57 |
ContentType | Journal Article |
Copyright | American College of Neuropsychopharmacology 2011 2015 INIST-CNRS Copyright Nature Publishing Group Mar 2011 Copyright © 2011 American College of Neuropsychopharmacology 2011 American College of Neuropsychopharmacology |
Copyright_xml | – notice: American College of Neuropsychopharmacology 2011 – notice: 2015 INIST-CNRS – notice: Copyright Nature Publishing Group Mar 2011 – notice: Copyright © 2011 American College of Neuropsychopharmacology 2011 American College of Neuropsychopharmacology |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PSYQQ Q9U 7X8 7TM 5PM |
DOI | 10.1038/npp.2010.208 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Proquest Medical Database Psychology Database Biological science database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic Nucleic Acids Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Nucleic Acids Abstracts |
DatabaseTitleList | Neurosciences Abstracts MEDLINE MEDLINE - Academic ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | DRD2 polymorphisms associated with cocaine abuse |
EISSN | 1740-634X |
EndPage | 762 |
ExternalDocumentID | PMC3055737 2262511741 21150907 24037436 10_1038_npp_2010_208 |
Genre | Journal Article Comparative Study Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: R01 DA022199 – fundername: NIGMS NIH HHS grantid: U01 GM092655 |
GroupedDBID | --- --K -DZ -Q- 0R~ 1B1 29N 2WC 36B 39C 3V. 4.4 406 53G 5RE 5VS 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AAEDT AALRI AANZL AAQFI AAQXK AASML AATNV AAXUO AAYZH AAZLF ABAKF ABIVO ABJNI ABLJU ABMAC ABUWG ABWVN ABZZP ACAOD ACGFO ACGFS ACIUM ACKTT ACMJI ACPRK ACRPL ACRQY ACZOJ ADBBV ADFRT ADHDB ADMUD ADNMO AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DWQXO E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FDB FDQFY FEDTE FERAY FGOYB FIGPU FIZPM FSGXE FYUFA GNUQQ GX1 HCIFZ HMCUK HVGLF HYE HZ~ IHE IWAJR JSO JZLTJ KQ8 LGEZI LOTEE M1P M2M M41 M7P MK0 NADUK NAO NQ- NQJWS NXXTH O9- OK1 P2P P6G PQQKQ PROAC PSQYO PSYQQ Q2X R2- RIG RNS RNT RNTTT ROL RPM RPZ SEW SNX SNYQT SOHCF SOJ SRMVM SSZ SV3 SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI ZKB AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ ACVFH ADCNI AEUPX AFPUW AGQPQ IQODW PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7TK 7XB 8FE 8FH 8FK K9. LK8 PKEHL PQEST PQUKI Q9U 7X8 7TM 5PM |
ID | FETCH-LOGICAL-c510t-63855e23e702cb020d3682b55c37c8ca8a6a68229837d65dbead5124d72a3a733 |
IEDL.DBID | 7X7 |
ISSN | 0893-133X 1740-634X |
IngestDate | Thu Aug 21 14:15:04 EDT 2025 Fri Jul 11 05:39:01 EDT 2025 Tue Aug 05 10:01:28 EDT 2025 Fri Jul 25 08:54:29 EDT 2025 Mon Jul 21 06:04:01 EDT 2025 Mon Jul 21 09:17:13 EDT 2025 Tue Jul 01 01:05:19 EDT 2025 Thu Apr 24 23:06:53 EDT 2025 Fri Feb 21 02:38:35 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | alternative splicing D2S DRD2 cocaine dopamine human Human Alternative splicing Drug addiction Dopamine CNS stimulant Psychotropic Catecholamine Ester D2 Dopamine receptor Neurotransmitter Cocaine Drug of abuse Polymorphism |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c510t-63855e23e702cb020d3682b55c37c8ca8a6a68229837d65dbead5124d72a3a733 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 |
OpenAccessLink | https://www.nature.com/articles/npp2010208.pdf |
PMID | 21150907 |
PQID | 850711152 |
PQPubID | 33935 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3055737 proquest_miscellaneous_907156466 proquest_miscellaneous_851476665 proquest_journals_850711152 pubmed_primary_21150907 pascalfrancis_primary_24037436 crossref_citationtrail_10_1038_npp_2010_208 crossref_primary_10_1038_npp_2010_208 springer_journals_10_1038_npp_2010_208 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-03-01 |
PublicationDateYYYYMMDD | 2011-03-01 |
PublicationDate_xml | – month: 03 year: 2011 text: 2011-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Basingstoke – name: England – name: New York |
PublicationSubtitle | At the intersection of brain, behavior, and therapeutics |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAbbrev | Neuropsychopharmacol |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2011 |
Publisher | Springer International Publishing Nature Publishing Group |
Publisher_xml | – name: Springer International Publishing – name: Nature Publishing Group |
References | WH Huang (BFnpp2010208_CR17) 2009; 34 A Bertolino (BFnpp2010208_CR4) 2010; 5 A Haliassos (BFnpp2010208_CR14) 1989; 17 CC Zai (BFnpp2010208_CR50) 2007; 10 JK Seamans (BFnpp2010208_CR39) 2004; 74 J Voisey (BFnpp2010208_CR44) 2009; 26 A Usiello (BFnpp2010208_CR43) 2000; 408 G Blasi (BFnpp2010208_CR5) 2009; 29 H Ishiguro (BFnpp2010208_CR21) 1998; 22 ZU Khan (BFnpp2010208_CR25) 1998; 95 Y Zhang (BFnpp2010208_CR52) 2007; 104 R Hwang (BFnpp2010208_CR19) 2006; 16 A Doehring (BFnpp2010208_CR7) 2009; 19 MJ Frank (BFnpp2010208_CR9) 2009; 164 AD Johnson (BFnpp2010208_CR23) 2005; 106 JW Smith (BFnpp2010208_CR40) 2002; 113 YY Wang (BFnpp2010208_CR47) 2000; 20 SE Hyman (BFnpp2010208_CR20) 2006; 29 Y Zhang (BFnpp2010208_CR53) 2005; 280 A Bertolino (BFnpp2010208_CR3) 2009; 132 GA Wray (BFnpp2010208_CR48) 2007; 8 JB Duan (BFnpp2010208_CR8) 2003; 12 MF Gosso (BFnpp2010208_CR13) 2008; 16 ND Volkow (BFnpp2010208_CR45) 1993; 14 SJ Glatt (BFnpp2010208_CR12) 2009; 14 PG Strange (BFnpp2010208_CR41) 1993; 22 B Le Foll (BFnpp2010208_CR28) 2009; 20 UW Preuss (BFnpp2010208_CR36) 2007; 42 MV Rockman (BFnpp2010208_CR37) 2002; 19 BR Lawford (BFnpp2010208_CR27) 2005; 73 MR Munafo (BFnpp2010208_CR32) 2004; 6 D Wang (BFnpp2010208_CR46) 2006; 16 C Lerman (BFnpp2010208_CR29) 2006; 31 ME Lull (BFnpp2010208_CR31) 2008; 1141 I Herzberg (BFnpp2010208_CR16) 2010; 20 AD Johnson (BFnpp2010208_CR24) 2008; 24 JP Zhang (BFnpp2010208_CR51) 2010; 167 R Xu (BFnpp2010208_CR49) 2002; 7 T Sasabe (BFnpp2010208_CR38) 2007; 412 A Haliassos (BFnpp2010208_CR15) 1989; 17 KA Frazer (BFnpp2010208_CR10) 2007; 449 M Lucht (BFnpp2010208_CR30) 2010; 34 XY Jiang (BFnpp2010208_CR22) 2009; 11 O Civelli (BFnpp2010208_CR6) 1993; 33 BK Thelma (BFnpp2010208_CR42) 2008; 9 TP Giordano (BFnpp2010208_CR11) 2006; 99 R Hwang (BFnpp2010208_CR18) 2005; 181 T Arinami (BFnpp2010208_CR1) 1997; 6 JK Pinsonneault (BFnpp2010208_CR35) 2006; 15 SH Kollins (BFnpp2010208_CR26) 2008; 147B MR Munafo (BFnpp2010208_CR33) 2007; 12 A Bertolino (BFnpp2010208_CR2) 2009; 29 AC Papp (BFnpp2010208_CR34) 2003; 34 8101394 - Synapse. 1993 Jun;14(2):169-77 2573037 - Nucleic Acids Res. 1989 Oct 25;17(20):8093-9 18382477 - Eur J Hum Genet. 2008 Sep;16(9):1075-82 18991951 - Ann N Y Acad Sci. 2008 Oct;1141:58-75 16123753 - Neuropsychopharmacology. 2006 Jan;31(1):231-42 16046395 - J Biol Chem. 2005 Sep 23;280(38):32618-24 17943122 - Nature. 2007 Oct 18;449(7164):851-61 15781120 - Pharmacol Ther. 2005 Apr;106(1):19-38 17304246 - Nat Rev Genet. 2007 Mar;8(3):206-16 16776597 - Annu Rev Neurosci. 2006;29:565-98 17196743 - Neurosci Lett. 2007 Jan 29;412(2):139-42 18077373 - Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20552-7 17026527 - J Neurochem. 2006 Nov;99(4):1197-206 12476322 - Mol Psychiatry. 2002;7(10):1075-82 18833581 - Depress Anxiety. 2009;26(1):28-33 12411608 - Mol Biol Evol. 2002 Nov;19(11):1991-2004 12765033 - Biotechniques. 2003 May;34(5):1068-72 15830237 - Psychopharmacology (Berl). 2005 Aug;181(1):179-87 8494342 - Annu Rev Pharmacol Toxicol. 1993;33:281-307 19176830 - J Neurosci. 2009 Jan 28;29(4):1224-34 19373123 - Pharmacogenet Genomics. 2009 Jun;19(6):407-14 18946637 - Neuromolecular Med. 2009;11(1):1-12 17453061 - Mol Psychiatry. 2007 May;12(5):454-61 8095172 - Neurochem Int. 1993 Mar;22(3):223-36 18821566 - Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1580-8 12554675 - Hum Mol Genet. 2003 Feb 1;12(3):205-16 16959057 - Int J Neuropsychopharmacol. 2007 Oct;10(5):639-51 18354387 - Neuropsychopharmacology. 2009 Jan;34(2):319-30 17001293 - Pharmacogenet Genomics. 2006 Oct;16(10):735-45 19179847 - Behav Pharmacol. 2009 Feb;20(1):1-17 9660310 - Alcohol Clin Exp Res. 1998 Jun;22(4):845-8 15381316 - Prog Neurobiol. 2004 Sep;74(1):1-58 20179754 - PLoS One. 2010;5(2):e9348 11069937 - J Neurosci. 2000 Nov 15;20(22):8305-14 18332877 - Mol Psychiatry. 2009 Sep;14(9):885-93 19393722 - Neuroscience. 2009 Nov 24;164(1):131-40 20431429 - Psychiatr Genet. 2010 Aug;20(4):179-83 16278074 - Eur Neuropsychopharmacol. 2006 May;16(4):248-59 15370155 - Nicotine Tob Res. 2004 Aug;6(4):583-97 19940176 - J Neurosci. 2009 Nov 25;29(47):14812-9 12182883 - Neuroscience. 2002;113(4):755-65 9097961 - Hum Mol Genet. 1997 Apr;6(4):577-82 18974171 - Bioinformatics. 2008 Dec 15;24(24):2938-9 19796663 - Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):45-9 15567074 - Schizophr Res. 2005 Feb 1;73(1):31-7 9636219 - Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7731-6 17526637 - Alcohol Alcohol. 2007 May-Jun;42(3):258-66 18781856 - Pharmacogenomics. 2008 Sep;9(9):1285-306 20194480 - Am J Psychiatry. 2010 Jul;167(7):763-72 18829695 - Brain. 2009 Feb;132(Pt 2):417-25 2726503 - Nucleic Acids Res. 1989 May 11;17(9):3606 11089973 - Nature. 2000 Nov 9;408(6809):199-203 16893905 - Hum Mol Genet. 2006 Sep 1;15(17):2636-49 |
References_xml | – volume: 17 start-page: 8093 year: 1989 ident: BFnpp2010208_CR14 publication-title: Nucleic Acids Res doi: 10.1093/nar/17.20.8093 – volume: 24 start-page: 2938 year: 2008 ident: BFnpp2010208_CR24 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btn564 – volume: 449 start-page: 851 year: 2007 ident: BFnpp2010208_CR10 publication-title: Nature doi: 10.1038/nature06258 – volume: 17 start-page: 3606 year: 1989 ident: BFnpp2010208_CR15 publication-title: Nucleic Acids Res doi: 10.1093/nar/17.9.3606 – volume: 280 start-page: 32618 year: 2005 ident: BFnpp2010208_CR53 publication-title: J Biol Chem doi: 10.1074/jbc.M504942200 – volume: 20 start-page: 8305 year: 2000 ident: BFnpp2010208_CR47 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.20-22-08305.2000 – volume: 26 start-page: 28 year: 2009 ident: BFnpp2010208_CR44 publication-title: Depress Anxiety doi: 10.1002/da.20517 – volume: 33 start-page: 281 year: 1993 ident: BFnpp2010208_CR6 publication-title: Ann Rev Pharmacol Toxicol doi: 10.1146/annurev.pa.33.040193.001433 – volume: 5 start-page: e9348 issue: 2 year: 2010 ident: BFnpp2010208_CR4 publication-title: Plos One doi: 10.1371/journal.pone.0009348 – volume: 74 start-page: 1 year: 2004 ident: BFnpp2010208_CR39 publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2004.05.006 – volume: 113 start-page: 755 year: 2002 ident: BFnpp2010208_CR40 publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00257-9 – volume: 106 start-page: 19 year: 2005 ident: BFnpp2010208_CR23 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2004.11.001 – volume: 6 start-page: 583 year: 2004 ident: BFnpp2010208_CR32 publication-title: Nicotine Tobacco Res doi: 10.1080/14622200410001734030 – volume: 34 start-page: 319 year: 2009 ident: BFnpp2010208_CR17 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.37 – volume: 132 start-page: 417 year: 2009 ident: BFnpp2010208_CR3 publication-title: Brain doi: 10.1093/brain/awn248 – volume: 29 start-page: 565 year: 2006 ident: BFnpp2010208_CR20 publication-title: Ann Rev Neurosci doi: 10.1146/annurev.neuro.29.051605.113009 – volume: 14 start-page: 169 year: 1993 ident: BFnpp2010208_CR45 publication-title: Synapse doi: 10.1002/syn.890140210 – volume: 16 start-page: 735 year: 2006 ident: BFnpp2010208_CR46 publication-title: Pharmacogenetics Genomics doi: 10.1097/01.fpc.0000230119.34205.8a – volume: 1141 start-page: 58 year: 2008 ident: BFnpp2010208_CR31 publication-title: Addiction Rev – volume: 9 start-page: 1285 year: 2008 ident: BFnpp2010208_CR42 publication-title: Pharmacogenomics doi: 10.2217/14622416.9.9.1285 – volume: 20 start-page: 1 year: 2009 ident: BFnpp2010208_CR28 publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e3283242f05 – volume: 181 start-page: 179 year: 2005 ident: BFnpp2010208_CR18 publication-title: Psychopharmacology doi: 10.1007/s00213-005-2223-5 – volume: 12 start-page: 454 year: 2007 ident: BFnpp2010208_CR33 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001938 – volume: 104 start-page: 20552 year: 2007 ident: BFnpp2010208_CR52 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0707106104 – volume: 29 start-page: 1224 year: 2009 ident: BFnpp2010208_CR2 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4858-08.2009 – volume: 14 start-page: 885 year: 2009 ident: BFnpp2010208_CR12 publication-title: Mol Psychiatry doi: 10.1038/mp.2008.30 – volume: 164 start-page: 131 year: 2009 ident: BFnpp2010208_CR9 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2009.04.048 – volume: 22 start-page: 845 year: 1998 ident: BFnpp2010208_CR21 publication-title: Alcohol Clin Exp Res – volume: 20 start-page: 179 year: 2010 ident: BFnpp2010208_CR16 publication-title: Psychiatr Genet doi: 10.1097/YPG.0b013e32833a215a – volume: 19 start-page: 407 year: 2009 ident: BFnpp2010208_CR7 publication-title: Pharmacogenetics Genomics doi: 10.1097/FPC.0b013e328320a3fd – volume: 167 start-page: 763 year: 2010 ident: BFnpp2010208_CR51 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2009.09040598 – volume: 6 start-page: 577 year: 1997 ident: BFnpp2010208_CR1 publication-title: Hum Mol Genet doi: 10.1093/hmg/6.4.577 – volume: 34 start-page: 45 year: 2010 ident: BFnpp2010208_CR30 publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2009.08.024 – volume: 34 start-page: 1068 year: 2003 ident: BFnpp2010208_CR34 publication-title: Biotechniques doi: 10.2144/03345dd03 – volume: 8 start-page: 206 year: 2007 ident: BFnpp2010208_CR48 publication-title: Nat Rev Genet doi: 10.1038/nrg2063 – volume: 42 start-page: 258 year: 2007 ident: BFnpp2010208_CR36 publication-title: Alcohol Alcohol doi: 10.1093/alcalc/agm030 – volume: 73 start-page: 31 year: 2005 ident: BFnpp2010208_CR27 publication-title: Schizophr Res doi: 10.1016/j.schres.2004.08.020 – volume: 31 start-page: 231 year: 2006 ident: BFnpp2010208_CR29 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300861 – volume: 7 start-page: 1075 year: 2002 ident: BFnpp2010208_CR49 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001145 – volume: 412 start-page: 139 year: 2007 ident: BFnpp2010208_CR38 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2006.10.064 – volume: 11 start-page: 1 year: 2009 ident: BFnpp2010208_CR22 publication-title: Neuromol Med doi: 10.1007/s12017-008-8051-0 – volume: 147B start-page: 1580 year: 2008 ident: BFnpp2010208_CR26 publication-title: Am J Med Genet BNeuropsychiatr Genet doi: 10.1002/ajmg.b.30876 – volume: 12 start-page: 205 year: 2003 ident: BFnpp2010208_CR8 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddg055 – volume: 16 start-page: 248 year: 2006 ident: BFnpp2010208_CR19 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2005.09.004 – volume: 22 start-page: 223 year: 1993 ident: BFnpp2010208_CR41 publication-title: Neurochem Int doi: 10.1016/0197-0186(93)90050-F – volume: 19 start-page: 1991 year: 2002 ident: BFnpp2010208_CR37 publication-title: Mol Biol Evol doi: 10.1093/oxfordjournals.molbev.a004023 – volume: 15 start-page: 2636 year: 2006 ident: BFnpp2010208_CR35 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddl192 – volume: 99 start-page: 1197 year: 2006 ident: BFnpp2010208_CR11 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2006.04186.x – volume: 29 start-page: 14812 year: 2009 ident: BFnpp2010208_CR5 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3609-09.2009 – volume: 408 start-page: 199 year: 2000 ident: BFnpp2010208_CR43 publication-title: Nature doi: 10.1038/35041572 – volume: 10 start-page: 639 year: 2007 ident: BFnpp2010208_CR50 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145706007152 – volume: 95 start-page: 7731 year: 1998 ident: BFnpp2010208_CR25 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.95.13.7731 – volume: 16 start-page: 1075 year: 2008 ident: BFnpp2010208_CR13 publication-title: Eur J Hum Genet doi: 10.1038/ejhg.2008.57 – reference: 12411608 - Mol Biol Evol. 2002 Nov;19(11):1991-2004 – reference: 18833581 - Depress Anxiety. 2009;26(1):28-33 – reference: 19940176 - J Neurosci. 2009 Nov 25;29(47):14812-9 – reference: 9660310 - Alcohol Clin Exp Res. 1998 Jun;22(4):845-8 – reference: 20179754 - PLoS One. 2010;5(2):e9348 – reference: 16046395 - J Biol Chem. 2005 Sep 23;280(38):32618-24 – reference: 20431429 - Psychiatr Genet. 2010 Aug;20(4):179-83 – reference: 11089973 - Nature. 2000 Nov 9;408(6809):199-203 – reference: 15370155 - Nicotine Tob Res. 2004 Aug;6(4):583-97 – reference: 12476322 - Mol Psychiatry. 2002;7(10):1075-82 – reference: 18781856 - Pharmacogenomics. 2008 Sep;9(9):1285-306 – reference: 19393722 - Neuroscience. 2009 Nov 24;164(1):131-40 – reference: 19179847 - Behav Pharmacol. 2009 Feb;20(1):1-17 – reference: 19176830 - J Neurosci. 2009 Jan 28;29(4):1224-34 – reference: 15830237 - Psychopharmacology (Berl). 2005 Aug;181(1):179-87 – reference: 17196743 - Neurosci Lett. 2007 Jan 29;412(2):139-42 – reference: 18382477 - Eur J Hum Genet. 2008 Sep;16(9):1075-82 – reference: 2726503 - Nucleic Acids Res. 1989 May 11;17(9):3606 – reference: 17453061 - Mol Psychiatry. 2007 May;12(5):454-61 – reference: 16959057 - Int J Neuropsychopharmacol. 2007 Oct;10(5):639-51 – reference: 18354387 - Neuropsychopharmacology. 2009 Jan;34(2):319-30 – reference: 18829695 - Brain. 2009 Feb;132(Pt 2):417-25 – reference: 19796663 - Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):45-9 – reference: 11069937 - J Neurosci. 2000 Nov 15;20(22):8305-14 – reference: 18946637 - Neuromolecular Med. 2009;11(1):1-12 – reference: 17943122 - Nature. 2007 Oct 18;449(7164):851-61 – reference: 8095172 - Neurochem Int. 1993 Mar;22(3):223-36 – reference: 15567074 - Schizophr Res. 2005 Feb 1;73(1):31-7 – reference: 8101394 - Synapse. 1993 Jun;14(2):169-77 – reference: 16123753 - Neuropsychopharmacology. 2006 Jan;31(1):231-42 – reference: 9097961 - Hum Mol Genet. 1997 Apr;6(4):577-82 – reference: 12765033 - Biotechniques. 2003 May;34(5):1068-72 – reference: 9636219 - Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7731-6 – reference: 17026527 - J Neurochem. 2006 Nov;99(4):1197-206 – reference: 17304246 - Nat Rev Genet. 2007 Mar;8(3):206-16 – reference: 18332877 - Mol Psychiatry. 2009 Sep;14(9):885-93 – reference: 19373123 - Pharmacogenet Genomics. 2009 Jun;19(6):407-14 – reference: 15381316 - Prog Neurobiol. 2004 Sep;74(1):1-58 – reference: 16776597 - Annu Rev Neurosci. 2006;29:565-98 – reference: 18991951 - Ann N Y Acad Sci. 2008 Oct;1141:58-75 – reference: 17526637 - Alcohol Alcohol. 2007 May-Jun;42(3):258-66 – reference: 12554675 - Hum Mol Genet. 2003 Feb 1;12(3):205-16 – reference: 8494342 - Annu Rev Pharmacol Toxicol. 1993;33:281-307 – reference: 18974171 - Bioinformatics. 2008 Dec 15;24(24):2938-9 – reference: 16278074 - Eur Neuropsychopharmacol. 2006 May;16(4):248-59 – reference: 18821566 - Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1580-8 – reference: 18077373 - Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20552-7 – reference: 12182883 - Neuroscience. 2002;113(4):755-65 – reference: 17001293 - Pharmacogenet Genomics. 2006 Oct;16(10):735-45 – reference: 16893905 - Hum Mol Genet. 2006 Sep 1;15(17):2636-49 – reference: 15781120 - Pharmacol Ther. 2005 Apr;106(1):19-38 – reference: 2573037 - Nucleic Acids Res. 1989 Oct 25;17(20):8093-9 – reference: 20194480 - Am J Psychiatry. 2010 Jul;167(7):763-72 |
SSID | ssj0015768 |
Score | 2.3837128 |
Snippet | The dopamine receptor D2 (encoded by
DRD2
) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this... The dopamine receptor D2 (encoded by DRD2) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 753 |
SubjectTerms | 631/208/2489/144 631/208/726/649 631/337/1645/1946 692/699/476/5 Addictive behaviors Adult Adult and adolescent clinical studies Alternative splicing Alternative Splicing - genetics Autopsy Behavioral Sciences Biological and medical sciences Biological Psychology Brain Brain - metabolism Brain - pathology Cocaine Cocaine-Related Disorders - genetics Cocaine-Related Disorders - metabolism Cocaine-Related Disorders - pathology Cortex (prefrontal) Dopamine D2 receptors Drug abuse Drug addiction Exons Female Genetic Predisposition to Disease HEK293 Cells Humans Introns Introns - genetics Linkage disequilibrium Male Medical sciences Medicine Medicine & Public Health Memory Mental disorders Middle Aged mRNA Neuropharmacology Neurosciences Original original-article Pharmacology. Drug treatments Pharmacotherapy Polymorphism, Single Nucleotide - genetics Psychiatry Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Putamen Receptors, Dopamine D2 - biosynthesis Receptors, Dopamine D2 - genetics Single-nucleotide polymorphism Young Adult |
Title | Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse |
URI | https://link.springer.com/article/10.1038/npp.2010.208 https://www.ncbi.nlm.nih.gov/pubmed/21150907 https://www.proquest.com/docview/850711152 https://www.proquest.com/docview/851476665 https://www.proquest.com/docview/907156466 https://pubmed.ncbi.nlm.nih.gov/PMC3055737 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgkxASQtBxCYPKD9AXFi2L40ueUNlFA2lTBZvUt8hxXG1SmwTSIvXfc47jpBQ2XvpQn9RuznH8nUu-Q8h7lotUW8nDmZil4KCYPEyTOAkB2oNHFEsVuReFLy7F-XXydcqnvjan8WWV3TPRPaiLymCM_FAhcAH4En-qf4TYNAqTq76DxkOyi8xlaNRy2vtbRwilHYhMWQgTT33de8TUYVnXbVlXjH0l_ziRntS6gZsza7ta3AU7_62e_CuF6k6ms2fkqYeUdNzawHPywJYDsjcuwZ1erOmIuiJPFz0fkEcXPpc-IKNJy1q9PqBXm5ewmgN3Rc9nvd4jqy9l2yiHTqr5elGBZm6bRUPHrhQElkTHcx9W_GXpd0yI45fVjLoMAT0Bv3wBU9KTmAJKtTW4-bBaSzvTsAXFcDA9hnMV5cb5qrEvyPXZ6dXxeei7NYQG9vUyhI3MuY2ZlVFsckChBRMqzjk3TBpltNJCC6SXB5e4ELzIwYYBbSSFjDXTkrGXZKesSvuaUA2ubS4MeGIsShJmcm0SZQxSoyle6CggHzuNZcZTmWNHjXnmUupMZaDfDPULHyogH3rpuqXwuEduuKX8XhgpCwFoiYDsd9aQ-Z3eZL1dBoT2o7BFMe-iS1utUOQokeAm8vtFUvgRLhIBc7xqrWszO2J2GA-I3LK7XgAJwrdHytsbRxSObG6SwZWjzkI3677rDrz57x_cJ4_bgDoW4L0lO8ufK_sOENkyH7p9NyS7n08vJ99-AwCRN3Y |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9NQwIkhKDjowyGH1hfWLTMTpz0AaFqZWrZOk2ik_oWHMcVk9okLC2ofxT_I3fORylsvO0lD_EldnJn-3535zuAdyKWXWUC35nKaRcBio6drsc9B1V7REQ8CF17UHh0LgeX3ueJP9mCX_VZGAqrrNdEu1AnmSYb-WFIiguqL_xj_t2holHkXK0raJRScWpWPxGxFR-GfWTvPucnn8bHA6cqKuBoFL-Fg_Lm-4YLE7hcx6gsJUKGPPZ9LQIdahUqqSRlQUfklkg_ifFX46boJQFXQgVk_8QV_x7uuy5hvWDS4LsjUt2t0toVDn7opIqzd0V4mOZ5GUbGqY7lHzvgo1wVyIxpWUXjJjX332jNv1y2dic8eQKPKxWW9UqZewpbJm3BTi9F-D5fsQ6zQaXWWt-C-6PKd9-CzkWZJXt1wMbrQ1_FgX2iyZ-92oHlMC0L87CLbLaaZygJV8W8YD0beoJDYr1ZZcb8YdgXcsDTzWzKrEeC9bNczbFL1ucMtWKTL7JrHK1htSiahJH5mR3jPk50vXhZmGdweSeMfA7baZaal8AUQulYakR-wvU8oWOlvVBrSsUW-oly2_C-5likq9TpVMFjFlkXvggj5G9E_MVL2Ib9hjovU4bcQre3wfyGmFIkomIn27BbS0NUrSxF1MyDNrCmFZcE8vOo1GRLIjnyAoSl_u0kXXyJLz2JfbwopWvdO2EEbG9DsCF3DQElJN9sSa--2cTklD0uEPhkp5bQ9bhv-gOv_vuBb-HBYDw6i86G56e78LA05lPw32vYXlwvzRvUBhfxnp2DDL7e9aT_DeIycT8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9NnTQhIQQdH2Uw_MD6wqIVO3HSB4TKumplrKpgk_oWHMcVk9okLC2ofxr_HXfORylsvO0lD_EldnJn-3cfvgN4LSLZVcb3nKmcdlFB0ZHTdbnrILRHjYj7QcceFD4fydNL9-PEm2zBr-osDIVVVmuiXajjVJON_Cgg4ILwhR9Ny6iIcX_wPvvuUAEpcrRW1TQKCTkzq5-oveXvhn1k9QHng5OL41OnLDDgaBTFhYOy53mGC-N3uI4QOMVCBjzyPC18HWgVKKkkZURHLS6WXhzhb8cN0o19roTyyRaKq_-2T0pRA7Y_nIzGn2sXBgF5C2G7wsHPnpRR9x0RHCVZVgSVcapq-cd-eD9TObJmWtTUuAn0_hu7-ZcD1-6Lg4fwoAS0rFdI4CPYMkkTdnsJKvPzFWszG2JqbfdN2DkvPflNaI-LnNmrQ3axPgKWH9on6mzaq11YDpOiTA8bp7PVPEW5uMrnOevZQBQcEuvNSqPmD8O-kDuebqZTZv0TrJ9mao5dsj5niJFNtkivcbSGVYJpYkbGaHaMuzrR9aJlbh7D5Z2w8gk0kjQxz4ApVKwjqVEPFB3XFTpS2g20psRsgRerTgveVBwLdZlInep5zELr0BdBiPwNib94CVpwUFNnRQKRW-j2N5hfE1PCRIR5sgV7lTSE5TqTh_WsaAGrW3GBIK-PSky6JJK3ro9Kqnc7SRdf4klXYh9PC-la904aA7a3wN-Qu5qA0pNvtiRX32yacsol5wt8sl1J6HrcN_2B5__9wFewgxM-_DQcne3BvcKyT5GAL6CxuF6alwgNF9F-OQkZfL3ref8bca122g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intronic+Polymorphisms+Affecting+Alternative+Splicing+of+Human+Dopamine+D2+Receptor+Are+Associated+with+Cocaine+Abuse&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Moyer%2C+Robert+A&rft.au=Wang%2C+Danxin&rft.au=Papp%2C+Audrey+C&rft.au=Smith%2C+Ryan+M&rft.date=2011-03-01&rft.issn=0893-133X&rft.volume=36&rft.issue=4&rft.spage=753&rft.epage=762&rft_id=info:doi/10.1038%2Fnpp.2010.208&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |